QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Structural analysis of the regulatory mechanism of marr protein rv2887 in m-tuberculosis 期刊论文 Scientific reports, 2017, 卷号: 7, 页码: 13 作者:  Gao, Yun-Rong;  Li, De-Feng;  Fleming, Joy;  Zhou, Ya-Feng;  Liu, Ying 收藏  |  浏览/下载：35/0  |  提交时间：2019/05/08 Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139 作者:  Lan, Jin-Shuai;  Ding, Yue;  Liu, Yun;  Kang, Ping;  Hou, Jian-Wei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Monoamine oxidase inhibitors  Acetylcholinesterase inhibitors  Multi-target ligand design  Alzheimer's disease  Coumarin derivatives   Molecular Determinants of Magnolol Targeting Both RXR alpha and PPAR gamma 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 11 作者:  Zhang, Haitao;  Xu, Xing;  Chen, Lili;  Chen, Jing;  Hu, Lihong 收藏  |  浏览/下载：16/0  |  提交时间：2019/01/08 An effective docking strategy for virtual screening based on multi-objective optimization algorithm 期刊论文 BMC BIOINFORMATICS, 2009, 卷号: 10 作者:  Li, Honglin;  Zhang, Hailei;  Zheng, Mingyue;  Luo, Jie;  Kang, Ling 收藏  |  浏览/下载：10/0  |  提交时间：2019/01/08 Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV 期刊论文 JOURNAL OF MOLECULAR RECOGNITION, 2008, 卷号: 21, 期号: 2, 页码: 122-131 作者:  Huang, Yanyan;  Zhao, Rui;  Luo, Jia;  Xiong, Shaoxiang;  Shangguan, Dihua 收藏  |  浏览/下载：12/0  |  提交时间：2019/04/09 Combinatorial Chemistry  High-performance Affinity Chromatography  Antisense Peptides  Potential Inhibitor  Sars-cov   LigBuilder: A multi-purpose program for structure-based drug design 期刊论文 journal of molecular modeling, 2000 Wang, RX; Gao, Y; Lai, LH 收藏  |  浏览/下载：21/0  |  提交时间：2015/11/11 structure-based drug design  automatic ligand construction  fragment-based approach  genetic algorithm  NOVO MOLECULAR DESIGN  PROTEIN-LIGAND COMPLEX  PRO-LIGAND  3-DIMENSIONAL STRUCTURE  BINDING-SITES  INHIBITORS  LUDI  GENERATION  THROMBIN  PEPTIDES